Ken Sharpe

Dr Ken Sharpe


ksharpe@unimelb.edu.au
(03) 8344 6995

Consulting

My areas of expertise include:
  • Experimental design
  • Analysis of categorical data (logistic regression, log-linear models)
  • General linear models
  • Quality control
Current and/or recent projects include:
  • Testing for the use of, prohibited, performance-enhancing, drugs in sport.
  • Calibration of scales used to assess competency in English among overseas students wishing to study in Australia.
  • Estimating the numbers of visitors to national parks.
  • Evaluation of factors that might influence the outcome of shoulder surgery.
  • Modelling the fatigue strength of cemented materials used in road construction.

Research

Areas of interest:

  • Analysis of categorical data
  • Discriminant analysis
  • Analysis of longitudinal data

Recent publications

2013

Ashenden M, Sharpe K, Habel J, Vicentin A, Schischka S. Improved alignment of reticulocyte counts between Sysmex XT-2000i instruments. J Clin Pathol. 2013 Mar; 66(3) :232-7.

Ashenden M, Clarke A, Sharpe K, d'Onofrio G, Plowman J, Gore CJ. Stability of athlete passport parameters during extended storage. Int J Lab Hematol. 2012 Oct 15. doi: 10.1111/ijlh.12014. [Epub ahead of print]

Gough CJ, Ashenden MJ, Sharpe K, Anson, JM, Saunders PU, Gore CJ. The effects of injury and illness on haemoglobin mass. Int J Sports Medicine. 2013 [Epub ahead of print]

Mørkeberg J, Sharpe K, Karstoft K, Ashenden MJ. Detection of microdoses of rhEPO with the MAIIA test. Scand J Med Sci Sports. 2013 Jan 24. doi: 10.1111/sms.12049. [Epub ahead of print]

2012

Eastwood A, Sharpe K, Bourdon PC, Woolford SM, Saunders PU, Robertson EY, Clark SA, Gore CJ. Within Subject Variation in Hemoglobin Mass in Elite Athletes. Med Sci Sports Exerc. 2012; 44(4) :725-32.

Ashenden M, Clarke A, Sharpe K, D'Onofrio, Allbon G and CJ Gore. Pre-analytical mixing of whole blood specimens in the context of the Athlete Passport. Journal of Clinical Pathology. 2012; 65(1) :8-13.

Ashenden M, Sharpe K, Garnham A, Gore CJ. Evaluation of the MAIIA dipstick test to detect recombinant human erythropoietin in plasma. J Pharm Biomed Anal. 2012; 67-68 :123-8.

Van Wyck DB, Giles I, Sharpe K. Within-patient variation of hemoglobin and reticulocytes: implications for evaluating ESA responsiveness in dialysis patients. Int J Lab Hematol. 2012; 34 :577-583.

Antoniades NC, Rochford PD, Pretto JJ, Pierce RJ, Gogler J, Steinkrug J, Sharpe K, McDonald CF. Pilot Study of Remote Telemonitoring in COPD. Telemed J E Health. 2012 Oct; 18(8) :634-40

2011

Mørkeberg J, Sharpe K, Belhage B, Damsgaard R, Schmidt W, Prommer N, Gore CJ, Ashenden MJ. Detecting autologous blood transfusions: a comparison of three passport approaches and four blood markers. Scand J Med Sci Sports. 2011; 21(2) :235-243.

Moore RP, Berlowitz DJ, Denehy L, Pretto JJ, Brazzale DJ, Sharpe K, Jackson B, McDonald CF. A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax. 2011; 66(1 ):32-7.

Ashenden M, Gough CE, Garnham A, Gore CJ, Sharpe K. Current markers of the Athlete Blood Passport do not flag microdose EPO doping. Eur J Appl Physiol. 2011; 111(9) :2307-14.

Gough CE, Sharpe K, Ashenden MJ, Anson JM, Saunders PU, Garvican LA, Bonetti DL, Gore CJ, Prommer N. Quality control technique to reduce the variability of longitudinal measurement of hemoglobin mass. Scand J Med Sci Sports. 2011; 21(6) :e365-71.

2009

PengWang, Sharpe K, Robins GL, Pattison PE. Exponential random graph (p?) models for affiliation networks. Social Networks. 2009; 31 :12-25.

Grossmann M, Panagiotopolous S, Sharpe K, Macisaac RJ, Clarke S, Zajac JD, Jerums G, Thomas MC. Low testosterone and anaemia in men with type 2 diabetes. Clin Endocrinol. 2009; 70 :547-553.

Mørkeberg J, Belhage B, Ashenden M, Bornø A, Sharpe K, Dziegiel MH, Damsgaard R. Screening for autologous blood transfusions. Int J Sports Med. 2009; 30 :285-92.

2008

Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, Macisaac RJ, Clarke S, Zajac JD, Jerums G. Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab. 2008; 93 :1834-40.

Gore CJ, Ashenden MJ, Sharpe K, Martin DT. Delta efficiency calculation in Tour de France champion is wrong. J Appl Physiol. 2008; 105 :1020.

2007

Slater GJ, Rice AJ, Sharpe K, Jenkins D and Hahn AG. Influence of Nutrient Intake after Weigh-In on Lightweight Rowing Performance. Med Sci Sports Exerc. 2007; 39(1):184-191.

Ashenden MJ, Schumacher YO, Sharpe K, Varlet-Marie E and Audran M.  Effects of Hemopuretrade mark on Maximal Oxygen Uptake and Endurance Performance in Healthy Humans. Int J Sports Med. 2007; 28(5) :381-5.

2006

Slater GJ, Rice AJ, Tanner R, Sharpe K, Jenkins D, Hahn AG. Impact of two different body mass management strategies on repeat rowing performance. Med Sci Sports Exerc. 2006; 38 :138-46.

G Slater, A J Rice, R Tanner, K Sharpe, C J Gore, D G Jenkins, A G Hahn. Acute weight loss followed by an aggressive nutritional recovery strategy has little impact on on-water rowing performance. Br J Sports Med. 2006; 40 :55–59.

Ken Sharpe and Michael J. Ashenden. A Third Generation approach to detect EPO abuse in athletes . To appear in Haematologica. 2006; 91 (3).

2005

Slater GJ, Rice AJ, Sharpe K, Mujika I, Jenkins D, Hahn AG. Body-mass management of Australian lightweight rowers prior to and during competition. Med Sci Sports Exerc. 2005; 37 :860-6.

Slater GJ, Rice AJ, Sharpe K, Tanner R, Jenkins D, Gore CJ, Hahn AG. Impact of acute weight loss and/or thermal stress on rowing ergometer performance. Med Sci Sports Exerc. 2005; 37 1:1387-94.

Slater GJ, Rice AJ, Mujika I, Hahn AG, Sharpe K, Jenkins DG. Physique traits of lightweight rowers and their relationship to competitive success. Br J Sports Med. 2005; 39: 736-41.

Pierce RJ, Sharpe K, Johns J, Thompson B. Pulmonary artery pressure and blood flow as predictors of outcome from lung cancer resection. Respirology. 2005; 10: 620-8.

2004

Muir JG, Yeow EGW, Keogh J, Pizzey C, Bird AR, Sharpe K, O‚Dea K, Macrae FA. Combining wheat bran with resistant starch has more beneficial effects on fecal indices than wheat bran alone. Am J Clin Nutr. 2004; 79 :1020-28.

Cole BL, Maddocks JD and Sharpe K. Visual search and the conspicuity of coloured targets for colour vision normal and colour vision deficient observers. Clin Exp Optom. 2004; 87 : 294-304.

Ashenden MJ, Sharpe K, Damsgaard R and Jarvis L. Standardization of Reticulocyte Values in an Antidoping Context. Am J Clin Pathol. 2004; 121 :816-825

Ashenden MJ, Sharpe K, Schoh C, Schumacher YO. Effect of pre-competition and altitude training on blood models used to detect erythropoietin abuse by athletes. Haematologica. 2004; 89 :1019-1020.

Ashenden MJ, Lacoste A, Orthant E, Audran M, Sharpe K. Longitudinal variation of hemoglobin and reticulocytes in elite rowers. Haematologica. 2004; 89 :1403-1404.

2003

Gore CJ, Parisotto R, Ashenden MJ, Stray-Gundersen J, Sharpe K, Hopkins W, Emslie KR, Howe C, Trout GJ, Kazlauskas R, Hahn AG. Second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica. 2003; 88 :333-44.

Parisotto R, Ashenden MJ, Gore CJ, Sharpe K, Hopkins W, Hahn AG. The effect of common hematologic abnormalities on the ability of blood models to detect erythropoietin abuse by athletes. Haematologica. 2003; 88 :931-40.

Ashenden MJ, Gore CJ, Parisotto R, Sharpe K, Hopkins WG, Hahn AG. Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica. 2003; 88 :1053-62.

Nelson M, Popp H, Sharpe K, Ashenden M. Proof of homologous blood transfusion through quantification of blood group antigens. Haematologica. 2003; 88 :1284-95.

2002

Sharpe K, Hopkins W, Emslie KR, Howe C, Trout GJ, Kazlauskas R, Ashenden MJ, Gore CJ, Parisotto R, Hahn A Development of reference ranges in elite athletes for markers of altered erythropoiesis. Haematologica. 2002; 87 :1248-1257

2001

Parisotto R, Wu M, Ashenden MJ, Emslie KR, Core CJ, Howe C, Kazauskas R, Sharpe K, Trout GJ, Xie M and Hahn AG. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis. Haematologica. 2001; 86 :128-137.

Teaching

Have taught numerous main-stream and service courses in Applied Statistics across year levels 1 to 4.